Weight Loss Program
Service Description
Wegovy also known as (Semaglutide), is an FDA-approved medication specifically designed for adult weight loss management and treatment of type 2 diabetes. Ozempic also known as (Semaglutide) treats type 2 diabetes and off label aides in adult weight loss. These two medications are GLP-1 receptor agonists, they increase insulin release, decrease hepatic glucose output, decrease gastric emptying, and suppresses appetite. Mounjaro also known as (Tirzepatide), works differently that other type 2 diabetes medications by directly activating GIP and GLP-1 pathways to help regulate blood sugar, slows down how quickly food leaves the stomach. Stops the liver from making and releasing too much sugar. Clinical studies have shown people taking once-weekly Mounjaro lost more weight that those taking Ozempic 1mg. *Treatment starts with low dose injection once a week and will gradual increase dose every 4 weeks. *Must commit to at least 3 months of treatment to see significant results. Patients should also incorporate weekly exercise to improve overall weight loss. -Side Effects- Like all medication side effects can occur. Most common side effects are 1.Abdominal pain 2.Headache 3.Low Blood Sugar 4.Nausea 5.Vomiting 6.Diarrhea 7.Dizziness 8.Constipation 9.Fatigue -Reduce side effects by eating slowly, increase fluids, avoid late night eating. -Weekly injections and weight will be monitored by Board Certified Family Nurse Practitioner. -Consult required to discuss medications, side effects, concerns and goals.
Contact Details
346 Route 25A suite 60, Rocky Point, NY 11778, USA
631-901-4765
Jonathonwenke@submergebotox.com
876 Sunrise Highway ste 23, Bay Shore, NY 11706, USA
631-901-4765
Jonathonwenke@submergebotox.com